Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
EBS
Emergent BioSolutions Inc. EBS
$8.08
โ–ผ -0.83% 24H
1.5634.5267.49100.45133.422006-112011-102016-082021-072026-06

About

Emergent BioSolutions Inc. is a global life sciences company that primarily focuses on the development, manufacturing, and distribution of a wide array of medical products. These products are designed to address public health threats including chemical and biological agents, and infectious diseases. As an important plaโ€ฆ

SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees900
TickerEBS

Statistics

Market Cap$418.5M
Revenue (TTM)$742.9M
Net Income$52.6M
Net Margin7.1%
EPS$0.93
P/E8.59
P/S0.64
P/B0.83
EV/EBITDA5.10
ROE-1.6%
Dividend Yieldโ€”
Price$8.08

Data: Twelve Data ยท Revenue = mcap / P/S

Emergent BioSolutions Inc. (EBS) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap